10.00
+2.56%
Close of 6 Nov 2026, in INR
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Mono Pharmacare
Its shares trade on NSE under the ticker MONOPHARMA.NS. It has been listed since 7 September 2023. In the fiscal year to 31 March 2025, it reported revenue of ₹1.68bn and net income of ₹30.9m. At that date it held total assets of ₹1.10bn and shareholders' equity of ₹312.0m.
Mono Pharmacare Ltd is a IN-based company operating in Health Care Providers & Services industry. The company is headquartered in Ahmedabad, Gujarat. The company went IPO on 2023-09-07. Mono Pharmacare Ltd is an India-based company, which is a distributor and supplier of a wide array of pharmaceutical products and medicines. The firm offers health care products, antibiotic medicines, cough, cold-anti-allergic medicines, antifungal medicines, nutraceutical medicines, analgesic and antipyretic medicines, antacid and antiemetics medicines, cardiac - diabetic medicines, and Cosmo care products. The Company’s segments are Marketing of Pharmaceutical Products, and Distributor of Pharmaceuticals Companies. Its portfolio comprises a wide range of drugs like antibiotics, antifungal, anti-cough cold and anti-allergic, antacid and antiemetics, analgesics and antipyretics, nutraceuticals, skincare, antiseptic, cardiac and diabetic and cosmetics.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Providers & Services
- Listed since
- 7 Sept 2023
- Website
- monopharmacareltd.com ↗
Leadership
Pay as last reported
- Mr. Panilam LakhatariyaExecutive Chairman of the Board, Managing Director, since 2022
- Mrs. Neha PrajapatiChief Financial Officer
- Mrs. Krupali ThakkarCompliance Officer, Company Secretary
- Mrs. Supal LakhatariyaExecutive Director, since 2022
- Mr. Archit ShahExecutive Director, since 2022
- Mr. Mitul SaparaNon-Executive Director
- Mr. Chintan TrivediNon-Executive Independent Director
- Mr. Gaurang VoraNon-Executive Independent Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Mono Pharmacare Ltd operates in the Health Care sector with a focus on pharmaceutical products and medicines.
- The company has a diverse portfolio including antibiotics, antifungals, and nutraceuticals.
- It offers both marketing and distribution services for pharmaceutical products.
Weaknesses
- The company is a distributor and supplier with limited information on its market share or competitive position.
- No specific details are provided about the company's financial performance or operational scale.
- The company's IPO occurred in 2023, indicating it is a relatively new market entrant.
Opportunities
- The growing health care industry in India presents potential for expansion.
- Diversification into new product categories like skincare and cosmetics could attract more customers.
- The company's focus on pharmaceutical distribution aligns with increasing demand for health care services.
Threats
- Competition from established pharmaceutical distributors may challenge market penetration.
- Regulatory changes in the health care sector could impact operations.
- The company's recent IPO in 2023 may expose it to market volatility and investor scrutiny.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.